Sfoglia per AUTORE
PISCAGLIA F
Collezione AO Ordine Mauriziano
Items : 2
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial. in ESMO open / ESMO Open. 2025 Feb;10(2):104110. doi: 10.1016/j.esmoop.2024.104110. Epub 2025 Jan 27.
2025
AO Ordine Mauriziano
AO Ordine Mauriziano
Piscaglia F; Masi G; Martinelli E; Cabibbo G; Di Maio M; Gasbarrini A; Iavarone M; Antonuzzo L; Mazzaferro V; Ballestrero A; Garufi C; Bergamo F; Celsa C; Marino D; Tovoli F; Ponziani FR; Pressiani T; Astolfi C; Gazzoli GC; Ciardiello F; Daniele B; Rimassa L;
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery. in JAMA surgery / JAMA Surg. 2023 Feb 1;158(2):192-202. doi: 10.1001/jamasurg.2022.6697.
2023
AO Ordine Mauriziano
AO Ordine Mauriziano
Aldrighetti L; Ferrero A; Romano F; Giuliante F; Dalla Valle R; Ruzzenente A; Grazi GL; Maestri M; Rossi M; Ercolani G; Baiocchi GL; Tarchi P; Frena A; Abu Hilal M; Zago M; Griseri G; Chiarelli M; Jovine E; Zanus G; Memeo R; Hasegawa K; Kawaguchi Y; Romano M; Delvecchio A; Valsecchi MG; Antonucci A; Piscaglia F; Farinati F; Ferrari C; et alii...